Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 1,823,520 5.900% |
1,823,520 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
RA Capital Management, L.P. | 58,267 9.900% |
3,318 (+6.04%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Ascendis Pharma A/S ASND |
RA Capital Management, L.P. | 5,865,338 10.900% |
46,476 (+0.80%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | BCTG Acquisition Corp. BCTG |
RA Capital Management, L.P. | 1,250,000 5.800% |
1,250,000 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 2,805,045 6.200% |
2,805,045 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
RA Capital Management, L.P. | 950,238 9.700% |
950,238 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC |
RA Capital Management, L.P. | 1,000,000 7.000% |
1,000,000 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Geron Corporation GERN |
RA Capital Management, L.P. | 31,114,941 9.990% |
31,114,941 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Helix Acquisition Corp. HLXA |
RA Capital Management, L.P. | 700,000 5.900% |
700,000 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | ImmunoGen, Inc. IMGN |
RA Capital Management, L.P. | 18,417,458 9.800% |
18,417,458 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RA Capital Management, L.P. | 4,285,161 9.800% |
4,285,161 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
RA Capital Management, L.P. | 2,129,003 5.600% |
2,129,003 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Kinnate Biopharma Inc. KNTE |
RA Capital Management, L.P. | 3,593,052 8.300% |
3,593,052 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Inozyme Pharma, Inc. INZY |
RA Capital Management, L.P. | 2,003,653 8.600% |
2,003,653 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
RA Capital Management, L.P. | 1,515,151 9.900% |
1,515,151 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Akouos, Inc. AKUS |
RA Capital Management, L.P. | 2,281,249 6.600% |
2,281,249 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
RA Capital Management, L.P. | 16,317 6.300% |
16,317 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | MacroGenics, Inc. MGNX |
RA Capital Management, L.P. | 4,375,217 7.800% |
4,375,217 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
RA Capital Management, L.P. | 2,150,404 5.400% |
2,150,404 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
RA Capital Management, L.P. | 1,770,023 6.000% |
1,770,023 (New Position) |
Filing History |